Senate Finance Committee on Tuesday said it asked the Department of Health to investigate the rebates to state Medicaid programs for Mylan's EpiPen treatment. » Read More
By: Kelly Evans
Michael Neidorff, Centene Chairman and CEO, shares his take on Obamacare and the state of health care ahead of the presidential election. » Read More
By: Scott Wapner
According to Bloomberg, Mylan may have misclassified its EpiPen product under certain Medicaid guidelines. CNBC's Dominic Chu reports the details. John Spallanzani, GFI Group chief macro strategist, and the "FMHR" traders weigh in. » Read More
The Company's preliminary review of all electronic requisitions submitted by the account during the time when the plaintiff was assigned at that office to be a phlebotomist reveals no apparent Medicare or other billing issues.
HMO stocks jumped on decisions on 2013 Medicare rates, but is this all roses? CNBC's Scott Cohn and Ipsita Smolinski, offer insight.
HMO stocks jumped on decisions on 2013 Medicare rates, with CNBC's Scott Cohn.
Health insurance stocks like Humana broke out sharply on Monday after the CMS increased the Medicare Advantage rate. The FMHR traders and Steve Grasso discuss how to play these stocks. Also, whether to get cautious on news the Dow has set a new intraday high in 12 of the past 20 trading sessions, with Jason Pride, Glenmede.
CNBC's Bertha Coombs explains how a change in budget calculations sent some health insurance shares higher.
CNBC's Bertha Coombs explains why the government's new program for Medicare and Medicaid has sent some insurers soaring.
Sarah James, Wedbush Securities analyst, reveals her outlook on health care companies, after a recent report indicates an estimated growth rate of 3.3% for insurers.
Following intense lobbying from the health insurance industry and members of Congress, the U.S. government said it will increase the payment rate for health insurers that offer coverage through the popular Medicare Advantage program.
Enrollment season for Medicare Advantage plans and Obama's health reform plan is six months away. One big question is how many people will show up to be insured, reports CNBC's Bertha Coombs.
A new study that estimates hospitals can expect to see a 25 percent growth in revenues from Medicaid money.
TUCSON, Ariz., March 18, 2013-- The following statement was issued by the Arizona State Chapter of the Association of American Physicians and Surgeons:. "Arizona's Governor Jan Brewer, like some other Republican governors who say they oppose ObamaCare, is pushing for implementation of a key feature of the Affordable Care Act: an expansion of Medicaid.
President Obama is warning that it may be impossible to reach a deal with Republicans on trimming the budget deficit.
Obamacare and the aging of doctors and patients are exacerbating the shortage of primary care physicians.
When Medicare was enacted, Congress promised that it would not interfere in the practice of medicine, or prevent patients from freely choosing a physician. Physicians enroll in Medicare by completing a form from the Centers for Medicare and Medicaid Services, Hansen explains.
Jan Brewer spoke to the press, backed up by dozens of physicians and nurses in medical attire, to promote passage of Medicaid expansion.
Spending on drugs to treat common diseases fell 1.5 percent among customers who receive prescription benefits through commercial insurers.